Results 51 to 60 of about 20,922 (100)

[Efficacy and safety of leukapheresis for hyperleukocytic leukemia]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2021
Tu YQ   +7 more
europepmc   +1 more source

[Analysis of risk factors for early death in hyperleukocytic acute leukemia]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Su MH   +8 more
europepmc   +1 more source

鼻咽癌病人淋巴细胞产生IL-2、IL-2受体活性及放射治疗对其影响的初步研究

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1989
我们对比了放射治疗前后鼻咽癌病人及正常对照者外周血淋巴细胞经PHA-M刺激后产生白细胞介素-2的能力和白细胞介素-2受体活性。结果发现鼻咽癌病人淋巴细胞产生白细胞介素-2的能力和白细胞介素-2受体的增殖活性均明显地低于正常对照,且在放射治疗后进一步下降。
doaj  

[The role and its regulatory significance of interleukin-25 in ovalbumin induced atopic dermatitis of mice]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Jin J, Chen X, Zhao Y, Jia J, Zhang J.
europepmc   +1 more source

白血病细胞相关抑制物对红细胞系造血影响的初步探讨

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1992
本文以体外红系祖细胞培养方法。观察白血病细胞相关抑制物对正常红系祖细胞(CFU-E)的抑制作用。10/10例初发未治急性白血病病人的白血病细胞培养液对CFU-E的生长均有抑制,抑制率25.4~67.4%,平均抑制率为44.35%。结果提示,白血病细胞相关抑制物对正常红细胞系造血也有抑制作用。
doaj  

[The role of hepatocyte programmed cell death in liver fibrosis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Zhou M, Zeng ZJ, Yang XK, Li H.
europepmc   +1 more source

Home - About - Disclaimer - Privacy